Showing results (211-220 of 234) with videos related to
Sort By:
Pageof 24
Tumori|April 11, 2019
The Italian Rare Pancreatic Exocrine Cancer InitiativeOronzo Brunetti, Claudio Luchini, Antonella Argentiero, et al.Plos One|January 4, 2014
Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis surveyDaniele Santini, Giuseppe Procopio, Camillo Porta, et al.Plos One|November 9, 2013
Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis surveyNicola Silvestris, Francesco Pantano, Toni Ibrahim, et al.Therapeutic Advances in Medical Oncology|February 4, 2020
Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a <i>post hoc</i> analysis from the adjuvant TOSCA trialSandro Barni, Gerardo Rosati, Sara Lonardi, et al.NPJ Breast Cancer|May 6, 2021
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in ItalyFrancesco Cognetti, Riccardo Masetti, Alessandra Fabi, et al.Advances in Therapy|February 1, 2020
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter StudyAlessandro Russo, Marco Russano, Tindara Franchina, et al.Journal of the National Cancer Institute|April 19, 2007
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trialStefano Cascinu, Roberto Labianca, Carlo Barone, et al.Journal of Experimental & Clinical Cancer Research : CR|February 6, 2015
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?Matteo Santoni, Alessandro Conti, Giuseppe Procopio, et al.European Journal of Cancer (Oxford, England : 1990)|June 6, 2019
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trialFrancesco Perrone, Michelino De Laurentiis, Sabino De Placido, et al.Plos One|September 5, 2015
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast CancerStefania Gori, Alessandro Inno, Elena Fiorio, et al.Pageof 24